TRAPPC4
Basic information
Region (hg38): 11:119018763-119025454
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy (Definitive), mode of inheritance: AR
- syndromic intellectual disability (Supportive), mode of inheritance: AD
- neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy (Limited), mode of inheritance: AR
- neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy (Strong), mode of inheritance: AR
- neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 31794024 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRAPPC4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 17 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | 4 | ||
non coding | 15 | 15 | ||||
Total | 0 | 1 | 17 | 0 | 18 |
Variants in TRAPPC4
This is a list of pathogenic ClinVar variants found in the TRAPPC4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-119018802-A-G | not specified • EBV-positive nodal T- and NK-cell lymphoma | Uncertain significance (Oct 04, 2022) | ||
11-119018805-T-G | not specified | Uncertain significance (Dec 16, 2021) | ||
11-119018811-G-A | not specified | Uncertain significance (Jan 17, 2024) | ||
11-119018815-ATG-A | Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy | Likely pathogenic (Nov 20, 2024) | ||
11-119018859-T-C | Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy | Uncertain significance (Aug 02, 2022) | ||
11-119018893-G-C | not specified | Uncertain significance (Jan 19, 2024) | ||
11-119018905-A-G | not specified | Uncertain significance (Sep 22, 2023) | ||
11-119018919-C-G | Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy | Uncertain significance (Jul 22, 2023) | ||
11-119018978-A-G | TRAPPC4-related disorder | Likely benign (Jan 05, 2022) | ||
11-119019100-C-T | Benign (May 15, 2021) | |||
11-119019103-C-G | Benign (May 15, 2021) | |||
11-119019112-C-G | Benign (May 15, 2021) | |||
11-119019140-C-T | Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy | Uncertain significance (Mar 12, 2021) | ||
11-119019158-T-C | Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy | Uncertain significance (-) | ||
11-119019161-C-T | not specified | Uncertain significance (Apr 07, 2023) | ||
11-119019174-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
11-119019193-A-G | not specified | Uncertain significance (Mar 24, 2023) | ||
11-119019227-G-A | Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy | Uncertain significance (Dec 20, 2021) | ||
11-119019245-C-T | Neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy | Uncertain significance (Jan 20, 2020) | ||
11-119019263-G-T | Uncertain significance (Oct 30, 2023) | |||
11-119019266-G-C | not specified | Uncertain significance (May 18, 2022) | ||
11-119019266-G-T | not specified | Uncertain significance (May 20, 2024) | ||
11-119019267-G-A | Benign (May 06, 2021) | |||
11-119019312-C-T | Benign (May 05, 2021) | |||
11-119019375-C-T | Benign (May 15, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRAPPC4 | protein_coding | protein_coding | ENST00000533632 | 5 | 7023 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000412 | 0.394 | 125711 | 0 | 36 | 125747 | 0.000143 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.428 | 106 | 119 | 0.890 | 0.00000526 | 1407 |
Missense in Polyphen | 36 | 43.975 | 0.81864 | 550 | ||
Synonymous | -2.49 | 69 | 47.2 | 1.46 | 0.00000218 | 446 |
Loss of Function | 0.448 | 9 | 10.6 | 0.851 | 5.49e-7 | 116 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000456 | 0.000456 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000123 | 0.000123 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.000261 | 0.000261 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in vesicular transport from endoplasmic reticulum to Golgi.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Extracellular matrix organization;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;Rab regulation of trafficking;Syndecan interactions;Non-integrin membrane-ECM interactions;RAB GEFs exchange GTP for GDP on RABs;COPII-mediated vesicle transport;ER to Golgi Anterograde Transport;Syndecan-2-mediated signaling events
(Consensus)
Recessive Scores
- pRec
- 0.145
Intolerance Scores
- loftool
- 0.580
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 33.97
Haploinsufficiency Scores
- pHI
- 0.0542
- hipred
- Y
- hipred_score
- 0.576
- ghis
- 0.653
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.842
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trappc4
- Phenotype
Gene ontology
- Biological process
- endoplasmic reticulum to Golgi vesicle-mediated transport;dendrite development;COPII vesicle coating
- Cellular component
- Golgi membrane;endoplasmic reticulum;Golgi stack;cytosol;synaptic vesicle;TRAPP complex;dendrite;synapse
- Molecular function
- protein binding;Rab guanyl-nucleotide exchange factor activity